Ultrapar acquisition of Extrafarma requires Brazilian antitrust approval
NYSE-listed Brazilian holding company Ultrapar’s plan to acquire drugstore chain Extrafarma requires Brazilian antitrust approval, the company said in a statement. The acquisition of one of Brazil’s largest drugstore chains, valued...To view the full article, register now.
Already a subscriber? Click here to view full article